NNOX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Nano-X Imaging Ltd (NNOX) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown slight revenue growth, its financial performance remains weak with negative net income, declining EPS, and gross margin. The technical indicators suggest a bearish trend, and there are no significant trading signals or catalysts to justify immediate action. A hold strategy is recommended until stronger positive signals or financial improvements are observed.
The stock's MACD is below zero and negatively contracting, indicating bearish momentum. RSI is neutral at 57.877, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 2.344, with resistance at 2.519 and support at 2.168. Overall, the technical outlook is bearish.
The company signed a distribution agreement with Elite Surgical Technologies to deploy its FDA-approved Nanox.ARC digital X-ray system in several U.S. states, which could lead to future revenue growth.
The company's financial performance remains weak, with negative net income, declining EPS, and gross margin. Additionally, there are no significant insider or hedge fund trading trends, and technical indicators suggest a bearish trend.
In Q3 2025, revenue increased by 13.72% YoY to $3,447,000. However, net income remains negative at -$13,684,000, improving only slightly by 0.33% YoY. EPS dropped by -8.70% YoY to -0.21, and gross margin declined by -9.87% YoY to -83.61%. Overall, the financial performance is weak.
No recent analyst ratings or price target changes are available for the stock.
